Anne Marzi
Overview
Explore the profile of Anne Marzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marzi A, Eder K, Barroso A, Kemper B, Schnekenburger J
Cells
. 2024 Apr;
13(8.
PMID: 38667312
The assessment of nanoparticle cytotoxicity is challenging due to the lack of customized and standardized guidelines for nanoparticle testing. Nanoparticles, with their unique properties, can interfere with biochemical test methods,...
2.
Martin S, de Haan L, Estruch I, Eder K, Marzi A, Schnekenburger J, et al.
Front Toxicol
. 2022 Sep;
4:974429.
PMID: 36171865
Engineered nanomaterials have been found to induce oxidative stress. Cellular oxidative stress, in turn, can result in the induction of antioxidant and detoxification enzymes which are controlled by the nuclear...
3.
Marzi A, Eder K, Barroso A, Wagbo A, Morch Y, Hatletveit A, et al.
Drug Deliv Transl Res
. 2022 Jul;
12(9):2207-2224.
PMID: 35799027
State-of-the-art in vitro test systems for nanomaterial toxicity assessment are based on dyes and several staining steps which can be affected by nanomaterial interference. Digital holographic microscopy (DHM), an interferometry-based...
4.
Eder K, Marzi A, Wagbo A, Vermeulen J, de la Fonteyne-Blankestijn L, Rosslein M, et al.
Drug Deliv Transl Res
. 2022 Jul;
12(9):2187-2206.
PMID: 35794354
Nanotechnologies such as nanoparticles are established components of new medical devices and pharmaceuticals. The use and distribution of these materials increases the requirement for standardized evaluation of possible adverse effects,...
5.
Eder K, Marzi A, Barroso A, Ketelhut S, Kemper B, Schnekenburger J
Cells
. 2022 Feb;
11(4).
PMID: 35203295
Cytotoxicity quantification of nanoparticles is commonly performed by biochemical assays to evaluate their biocompatibility and safety. We explored quantitative phase imaging (QPI) with digital holographic microscopy (DHM) as a time-resolved...